Antares Pharma Inc (ATRS) Exchange: NASDAQ

Data as of April 26, 2024

$5.59 ($0.00) 0.00%

Antares Pharma Inc - Daily Information
Click for more stock information on Antares Pharma Inc.
Daily Information Data
Date April 26, 2024
Open $5.59
Previous Close $5.59
High $5.59
Low $5.59
Adjusted Open $5.59
Previous Adjusted Close $5.59
Adjusted High $5.59
Adjusted Low $5.59

About Antares Pharma Inc (ATRS)

Antares Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma’s FDA-approved products include XYOSTED ® (testosterone enanthate) injection and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA ® (desmopressin acetate) in the U.S. and expects to commercially launch TLANDO ® (testosterone undecanoate) in the U.S. pending final FDA approval. About Assertio Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions.

Historical Stock Data for Antares Pharma Inc (ATRS)

Date Open High Low Close Adj.Close Volume
2022-09-07 $5.59 $5.59 $5.59 $5.59 $5.59 6
2022-08-26 $5.59 $5.59 $5.59 $5.59 $5.59 612
2022-08-25 $5.59 $5.59 $5.59 $5.59 $5.59 1,304
2022-08-09 $5.59 $5.59 $5.59 $5.59 $5.59 4,776
2022-08-05 $5.59 $5.59 $5.59 $5.59 $5.59 1,800
2022-08-04 $5.59 $5.59 $5.59 $5.59 $5.59 2,436
2022-08-03 $5.59 $5.59 $5.59 $5.59 $5.59 1,082
2022-07-29 $5.59 $5.59 $5.59 $5.59 $5.59 14
2022-07-19 $5.59 $5.59 $5.59 $5.59 $5.59 1,810
2022-07-18 $5.59 $5.59 $5.59 $5.59 $5.59 4,960
2022-07-15 $5.59 $5.59 $5.59 $5.59 $5.59 695
2022-07-11 $5.59 $5.59 $5.59 $5.59 $5.59 10
2022-07-07 $5.59 $5.59 $5.59 $5.59 $5.59 4,200
2022-06-29 $5.59 $5.59 $5.59 $5.59 $5.59 435
2022-06-10 $5.59 $5.59 $5.59 $5.59 $5.59 135
2022-06-09 $5.59 $5.59 $5.59 $5.59 $5.59 435
2022-06-08 $5.59 $5.59 $5.59 $5.59 $5.59 300
2022-06-06 $5.59 $5.59 $5.59 $5.59 $5.59 100

Antares Pharma Inc (ATRS) News Headlines

Recent Antares Pharma Inc (ATRS) News

All investments involve risks and is not suitable for every investor. The value of securities may fluctuate and as a result, clients may lose more than their original investment. The past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing.

No content on the Nuvestan website shall be considered a recommendation or solicitation for the purchase or sale of securities, options, or other investment products. All information and data on the website are for reference only, and no historical data shall be considered as the basis for judging future trends.

Terms of Use, features, support, and service options subject to change without notice.

Nuvestan Logo

© Nuvestan Inc.